The results showed that low expression of C10orf10 might be an unfavorable factor for the prognosis of BC patients who were luminal A, luminal B, Her2+ subtypes, at histological grade 2, lymph node negative and ER positive. The gene discussed is ERBB2; the disease is breast cancer.